Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 8,040 shares at $15.93 ($128K) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $128k VNDA by SVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.93 | 4,020 | $64K | 50.0% |
| 2 | $15.93 | 4,020 | $64K | 50.0% |
| Total | $15.93 avg | 8,040 | $128K | 100% |
| Filing → |
| VNDA | SELL | 2023-03-06 | $209K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |